Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136851
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2005-08-26
Brief Title:
Study Comparing the Efficacy of Amlodipine BesylateBenazepril Versus Amlodipine in the Treatment of Severe Hypertension
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Study Overview
Official Title:
A 6-Week Multi-center Randomized Double-Blind Parallel Group Study Comparing the Efficacy of Amlodipine BesylateBenazepril Versus Amlodipine in the Treatment of Severe Hypertension
Status:
COMPLETED
Status Verified Date:
2006-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is designed to study the efficacy of an amlodipine besylatebenazepril treatment regimen versus an amlodipine treatment regimen in the treatment of severe hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None